Plunkett Research Online: NovelStem International Corp

NOVELSTEM INTERNATIONAL CORP (NSTM:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

NovelStem International Corp owns novel stem-cell-based diagnostic technology for predicting patients' resistance to cancer therapies. The technology is also being used for genetic research related to other medical therapies......



NovelStem International Corp
Ticker: NSTM
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 561 998-8000
Fax: 561 998-2974
Address: 2255 Glades Road
Suite 221A
Boca Raton, FL 33431 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

In-Vitro Diagnostic Substance Manufacturing
Contacts Description
Ayelet Dilion-MashiahCEO
Jan LoebChairman of the Board/Director
See More
NovelStem International Corp owns novel stem-cell-based diagnostic technology for predicting patients' resistance to cancer therapies. The technology is also being used for genetic research related to other medical therapies......See More See More

Auditor: Kreit & Chiu CPA LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NewStem Ltd.
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: